Amneal Pharmaceuticals, Inc.: capex

Value{"amount": 43216000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityAmneal Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001723128-24-000014 · Open the official SEC filing →
Retrieved: 2026-08-19T17:37:46.930960+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001723128/capex/2023-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/5afea55a-709f-4f7c-befa-b06b1f740d30

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies